785 related articles for article (PubMed ID: 26373574)
21. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
22. Targeting fibroblast growth factor receptor pathway in breast cancer.
Criscitiello C; Esposito A; De Placido S; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):452-6. PubMed ID: 26397764
[TBL] [Abstract][Full Text] [Related]
23. Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images.
Velmahos CS; Badgeley M; Lo YC
Cancer Med; 2021 Jul; 10(14):4805-4813. PubMed ID: 34114376
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
Jardim DLF; Millis SZ; Ross JS; Lippman S; Ali SM; Kurzrock R
Oncologist; 2023 Feb; 28(2):e82-e91. PubMed ID: 36082904
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer.
Moes-Sosnowska J; Chorostowska-Wynimko J
Front Oncol; 2022; 12():780650. PubMed ID: 35402233
[TBL] [Abstract][Full Text] [Related]
26. A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.
Chiba Y; Sudo K; Kojima Y; Okuma H; Kohsaka S; Machida R; Ichimura M; Anjo K; Kurishita K; Okita N; Nakamura K; Kinoshita I; Takahashi M; Matsubara J; Kusaba H; Yonemori K; Takahashi M
BMC Cancer; 2022 Aug; 22(1):869. PubMed ID: 35945547
[TBL] [Abstract][Full Text] [Related]
27. Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers.
Brown LM; Ekert PG; Fleuren EDG
Oncogene; 2023 Jun; 42(23):1875-1888. PubMed ID: 37130917
[TBL] [Abstract][Full Text] [Related]
28. Identification of targetable FGFR gene fusions in diverse cancers.
Wu YM; Su F; Kalyana-Sundaram S; Khazanov N; Ateeq B; Cao X; Lonigro RJ; Vats P; Wang R; Lin SF; Cheng AJ; Kunju LP; Siddiqui J; Tomlins SA; Wyngaard P; Sadis S; Roychowdhury S; Hussain MH; Feng FY; Zalupski MM; Talpaz M; Pienta KJ; Rhodes DR; Robinson DR; Chinnaiyan AM
Cancer Discov; 2013 Jun; 3(6):636-47. PubMed ID: 23558953
[TBL] [Abstract][Full Text] [Related]
29. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
30. Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations.
Gallo LH; Nelson KN; Meyer AN; Donoghue DJ
Cytokine Growth Factor Rev; 2015 Aug; 26(4):425-49. PubMed ID: 26003532
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.
Chang J; Liu X; Wang S; Zhang Z; Wu Z; Zhang X; Li J
PLoS One; 2014; 9(8):e105524. PubMed ID: 25171497
[TBL] [Abstract][Full Text] [Related]
32. Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours.
Parker BC; Engels M; Annala M; Zhang W
J Pathol; 2014 Jan; 232(1):4-15. PubMed ID: 24588013
[TBL] [Abstract][Full Text] [Related]
33. FGFR as potential target in the treatment of squamous non small cell lung cancer.
Tiseo M; Gelsomino F; Alfieri R; Cavazzoni A; Bozzetti C; De Giorgi AM; Petronini PG; Ardizzoni A
Cancer Treat Rev; 2015 Jun; 41(6):527-39. PubMed ID: 25959741
[TBL] [Abstract][Full Text] [Related]
34. Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.
Malchers F; Dietlein F; Schöttle J; Lu X; Nogova L; Albus K; Fernandez-Cuesta L; Heuckmann JM; Gautschi O; Diebold J; Plenker D; Gardizi M; Scheffler M; Bos M; Seidel D; Leenders F; Richters A; Peifer M; Florin A; Mainkar PS; Karre N; Chandrasekhar S; George J; Silling S; Rauh D; Zander T; Ullrich RT; Reinhardt HC; Ringeisen F; Büttner R; Heukamp LC; Wolf J; Thomas RK
Cancer Discov; 2014 Feb; 4(2):246-57. PubMed ID: 24302556
[TBL] [Abstract][Full Text] [Related]
35. Genomic landscape of salivary gland tumors.
Kato S; Elkin SK; Schwaederle M; Tomson BN; Helsten T; Carter JL; Kurzrock R
Oncotarget; 2015 Sep; 6(28):25631-45. PubMed ID: 26247885
[TBL] [Abstract][Full Text] [Related]
36. Complexity of FGFR signalling in metastatic urothelial cancer.
Rodriguez-Vida A; Saggese M; Hughes S; Rudman S; Chowdhury S; Smith NR; Lawrence P; Rooney C; Dougherty B; Landers D; Kilgour E; Arkenau HT
J Hematol Oncol; 2015 Oct; 8():119. PubMed ID: 26497743
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application.
Chae YK; Ranganath K; Hammerman PS; Vaklavas C; Mohindra N; Kalyan A; Matsangou M; Costa R; Carneiro B; Villaflor VM; Cristofanilli M; Giles FJ
Oncotarget; 2017 Feb; 8(9):16052-16074. PubMed ID: 28030802
[TBL] [Abstract][Full Text] [Related]
38. Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology.
Patel SP; Schwaederle M; Daniels GA; Fanta PT; Schwab RB; Shimabukuro KA; Kesari S; Piccioni DE; Bazhenova LA; Helsten TL; Lippman SM; Parker BA; Kurzrock R
Oncotarget; 2015 Oct; 6(32):32602-9. PubMed ID: 26418953
[TBL] [Abstract][Full Text] [Related]
39. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
[TBL] [Abstract][Full Text] [Related]
40. Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.
Paik PK; Shen R; Won H; Rekhtman N; Wang L; Sima CS; Arora A; Seshan V; Ladanyi M; Berger MF; Kris MG
Cancer Discov; 2015 Jun; 5(6):610-21. PubMed ID: 25929848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
